149 related articles for article (PubMed ID: 9405998)
21. Evaluation of apoptosis and necrosis induction in cultured cells of lung carcinomas under effect of cytostatic drugs in vitro.
Drag-Zalesińska M; Wysocka T; Gebarowska E; Zabel M
Folia Histochem Cytobiol; 1999; 37(2):133-4. PubMed ID: 10352994
[No Abstract] [Full Text] [Related]
22. [Chemosensitivity test for gastric cancer by in vitro MTT assay].
Ohyama S; Yonemura Y; Kinoshita K; Ninomiya I; Tugawa K; Kimura H; Miyazaki I; Tanaka M; Endo Y; Sasaki T
Gan To Kagaku Ryoho; 1991 Aug; 18(10):1593-7. PubMed ID: 1908213
[TBL] [Abstract][Full Text] [Related]
23. Expression of the major vault protein LRP in human non-small-cell lung cancer cells: activation by short-term exposure to antineoplastic drugs.
Berger W; Elbling L; Micksche M
Int J Cancer; 2000 Oct; 88(2):293-300. PubMed ID: 11004683
[TBL] [Abstract][Full Text] [Related]
24. Combined treatment with low-dose interferon plus vinblastine is associated with less toxicity than conventional interferon monotherapy in patients with metastatic renal cell carcinoma.
Tsavaris N; Skarlos D; Bacoyiannis C; Aravantinos G; Kosmas C; Retalis G; Panopoulos C; Vadiaka M; Dimitrakopoulos A; Kostantinidis K; Mitropoulos D; Bougas D; Pantazopoulos D; Kosmidis P
J Interferon Cytokine Res; 2000 Aug; 20(8):685-90. PubMed ID: 10954911
[TBL] [Abstract][Full Text] [Related]
25. [Effect of anticancer agents on rat prostate. Evaluation of organ weight, histological finding and 5 alpha-reductase activities].
Takeda M; Hosaka M; Kitajima N; Noguchi K; Fujii H; Oshima H; Harada M
Hinyokika Kiyo; 1985 Jan; 31(1):71-80. PubMed ID: 2581430
[TBL] [Abstract][Full Text] [Related]
26. Phase I trial of 40-kd branched pegylated interferon alfa-2a for patients with advanced renal cell carcinoma.
Motzer RJ; Rakhit A; Ginsberg M; Rittweger K; Vuky J; Yu R; Fettner S; Hooftman L
J Clin Oncol; 2001 Mar; 19(5):1312-9. PubMed ID: 11230473
[TBL] [Abstract][Full Text] [Related]
27. Interferon-alpha and -gamma in combination with chemotherapeutic drugs: in vitro sensitivity studies in four human mesothelioma cell lines.
Hand AM; Husgafvel-Pursiainen K; Pelin K; Vallas M; Suitiala T; Ekman A; Mattson M; Mattson K; Linnainmaa K
Anticancer Drugs; 1992 Dec; 3(6):687-94. PubMed ID: 1288739
[TBL] [Abstract][Full Text] [Related]
28. [Chemotherapy of renal cell carcinoma: experimental study and clinical effect].
Kanda H; Matsuura T; Akiyama T; Kurita T
Hinyokika Kiyo; 1988 Nov; 34(11):1879-84. PubMed ID: 3242362
[TBL] [Abstract][Full Text] [Related]
29. Cellular levels of thioredoxin associated with drug sensitivity to cisplatin, mitomycin C, doxorubicin, and etoposide.
Yokomizo A; Ono M; Nanri H; Makino Y; Ohga T; Wada M; Okamoto T; Yodoi J; Kuwano M; Kohno K
Cancer Res; 1995 Oct; 55(19):4293-6. PubMed ID: 7671238
[TBL] [Abstract][Full Text] [Related]
30. A combination of vinblastine and doxorubicin with interferon alpha.
Jekunen A; Pyrhönen S
Am J Clin Oncol; 1996 Aug; 19(4):384-5. PubMed ID: 8677910
[TBL] [Abstract][Full Text] [Related]
31. Prediction of in vitro response to interferon-alpha in renal cell carcinoma cell lines.
Shimazui T; Ami Y; Yoshikawa K; Uchida K; Kojima T; Oikawa T; Nakamura K; Honda N; Hinotsu S; Miyazaki J; Kunita N; Akaza H
Cancer Sci; 2007 Apr; 98(4):529-34. PubMed ID: 17284252
[TBL] [Abstract][Full Text] [Related]
32. Test for chemotherapeutic sensitivity of cerebral gliomas: use of colorimetric MTT assay.
Jordan JP; Hand CM; Markowitz RS; Black P
J Neurooncol; 1992 Sep; 14(1):19-35. PubMed ID: 1335043
[TBL] [Abstract][Full Text] [Related]
33. Characterization of four doxorubicin adapted human breast cancer cell lines with respect to chemotherapeutic drug sensitivity, drug resistance associated membrane proteins and glutathione transferases.
de la Torre M; Hao XY; Larsson R; Nygren P; Tsuruo T; Mannervik B; Bergh J
Anticancer Res; 1993; 13(5A):1425-30. PubMed ID: 7902062
[TBL] [Abstract][Full Text] [Related]
34. Interferon alfa-2a and 13-cis-retinoic acid in renal cell carcinoma: antitumor activity in a phase II trial and interactions in vitro.
Motzer RJ; Schwartz L; Law TM; Murphy BA; Hoffman AD; Albino AP; Vlamis V; Nanus DM
J Clin Oncol; 1995 Aug; 13(8):1950-7. PubMed ID: 7636535
[TBL] [Abstract][Full Text] [Related]
35. Treatment with tumor necrosis factor alpha and interferon alpha of a human kidney cancer xenograft in nude mice: evidence for an anticachectic effect of interferon alpha.
Bassukas ID; Hofmockel G; Maurer-Schultze B
Anticancer Res; 1994; 14(1A):237-45. PubMed ID: 8166454
[TBL] [Abstract][Full Text] [Related]
36. [In vitro drug sensitivity testing and chemotherapy of lung cancer].
Liao ML
Zhonghua Jie He He Hu Xi Za Zhi; 1993 Dec; 16(6):345-6, 374. PubMed ID: 8033231
[TBL] [Abstract][Full Text] [Related]
37. Intrinsic chemotherapy resistance to the tubulin-binding antimitotic agents in renal cell carcinoma.
Ferguson RE; Jackson SM; Stanley AJ; Joyce AD; Harnden P; Morrison EE; Patel PM; Phillips RM; Selby PJ; Banks RE
Int J Cancer; 2005 May; 115(1):155-63. PubMed ID: 15645438
[TBL] [Abstract][Full Text] [Related]
38. Clinical and immunologic effects of subcutaneously administered interleukin-12 and interferon alfa-2b: phase I trial of patients with metastatic renal cell carcinoma or malignant melanoma.
Alatrash G; Hutson TE; Molto L; Richmond A; Nemec C; Mekhail T; Elson P; Tannenbaum C; Olencki T; Finke J; Bukowski RM
J Clin Oncol; 2004 Jul; 22(14):2891-900. PubMed ID: 15254058
[TBL] [Abstract][Full Text] [Related]
39. Biomodulation of 5-fluorouracil by interferon-alpha in human renal carcinoma cells: relationship to the expression of thymidine phosphorylase.
Morita T; Tokue A
Cancer Chemother Pharmacol; 1999; 44(2):91-6. PubMed ID: 10412941
[TBL] [Abstract][Full Text] [Related]
40. [Enhancement of cytotoxicity of anticancer drugs by verapamil--effects on established human renal tumor cell line].
Watanabe Y
Nihon Hinyokika Gakkai Zasshi; 1988 Jan; 79(1):11-9. PubMed ID: 3398369
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
